Background

Several years ago, ISPOR convened an ad hoc advisory body of healthcare decision makers to provide strategies to ISPOR on bridging the gap between outcomes research and healthcare decisions (Healthcare Strategy Council). Key issues identified by this advisory body were education/training, health policy/market force, methods/standards, information availability/access/sharing/applicability, and credibility/integrity/bias. ISPOR has implemented many educational programs and addresses methods/standards and credibility/integrity/bias through its Good Practices for Outcomes Research. However, information availability/applicability/access/sharing were issues which could best be addressed by professionals who use outcomes research information to develop evidence to inform healthcare decision makers. Since health technology assessment (HTA) informs many healthcare decision makers - regulatory agencies, healthcare payers, clinicians, hospitals, clinics, health authorities, and patient groups, the ISPOR Health Technology Assessment Roundtables were formed.

Mission

The mission of the ISPOR Health Technology Assessment Council is to:

  • Provide a platform for regional ISPOR HTA Roundtables to share issues and recommendations
  • Provide guidance in the translation and use of outcomes studies as useful information in the health technology assessment and healthcare decision-making processes.
  • Address issues and concerns of decision makers globally.
  • Assist in the development and implementation of initiatives related to use of outcomes research information by healthcare decision makers.

Membership and Structure

 

Council Structure

 

Council Chair

Brian O'Rourke, PharmD

President, Brian O'Rourke Health Care Consulting Inc.
Ottawa, ON, Canada

Asia Pacific Roundtable Chair

Izzuna Mudla Mohamed Ghazali, MBBS, MPH
Head, Malaysian Health Technology Assessment Section (MaHTAS), Medical Development Division
Ministry of Health
Kuala Lumpur, Malaysia

Europe Roundtable Co-Chairs

Iga Lipska, MD, PhD, MPH
Former Research Project Manager and Former Leader Hospital-Based HTA Program, HQ National Health Fund
Vice Director, Clinical Trial Center, Medical University of Gdańsk
Gdańsk, Poland

Máirín Ryan, PhD
Director of Health Technology
Health Information and Quality Authority (HIQA)
Dublin, Ireland

Latin America Roundtable Chair

Sebastián García Martí, MD, MSc
Coordinator, Health Technology Assessment and Economic Evaluations, Institute for Clinical Effectiveness and Health Policy (IECS)
Researcher, National Scientific and Technical Research Council (CONICET)
Buenos Aires, Argentina

Middle East and Africa Roundtable Chair

Mouna Jameleddine Chtioui, PharmD, MSc
Director, HTA Department, Instance Nationale de l’Evaluation & de l’Accréditation en Santé (INEAS)
Vice-Chair, The International Network of Agencies for Health Technology Assessment (INAHTA)
Tunis, Tunisia

Pharmacy & Therapeutics Roundtable North America Co-chairs

C. Bernie Good, MD, MPH
Senior Medical Director, Center for Value-Based Pharmacy Initiatives
UPMC Health Plan
Pittsburgh, PA, USA

Suzanne McGurn, MPA
President & Chief Executive Officer
Canadian Agency for Drugs and Technologies in Health (CADTH)
Ottawa, ON, Canada


Working Groups


  • Challenges of Health Technology Assessment (HTA) In Pluralistic Healthcare Systems: An ISPOR HTA Council Working Group

Roundtables



For More Information

For more information about health technology assessment, please see HTA Central.

Please contact us for information about the Health Technology Assessment Council, Roundtables, or other HTA initiatives.

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×